CFO
TMO icon

Cambient Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Cambient Family Office’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
868
-210
-19% -$101K 0.05% 165
2026
Q1 		$530K Buy
1,078
+205
+23% +$111K 0.07% 141
2025
Q4 		$506K Buy
+873
New +$494K 0.07% 132

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cambient Family Office's TMO Position: Q2 2026 in Review

Cambient Family Office reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, selling an estimated $101K and leaving 868 shares worth $436K. The position accounts for 0.05% of the portfolio, ranked #165.

Cambient Family Office first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $530K in Q1 2026. 2,613 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cambient Family Office held 868 shares of Thermo Fisher Scientific worth $436K as of Q2 2026.
  • Cambient Family Office sold 210 Thermo Fisher Scientific shares in Q2 2026, an estimated $101K.
  • Thermo Fisher Scientific made up 0.05% of Cambient Family Office's portfolio in Q2 2026, its #165 holding.
  • Cambient Family Office first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Cambient Family Office's Thermo Fisher Scientific position peaked at $530K in Q1 2026.
  • 2,613 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.